Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/7/2019
SIETES contiene 92793 citas

 
 
<< anterior 21 a 40 de 512 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
Dyer O. Major publisher retracts 43 papers, alleging fake peer review. BMJ 2015;350:h1783. [Ref.ID 98943]
22. Cita con resumen
Anderson ML, Chiswell K, Peterson ED, Tasneem A, Topping J, Califf RM. Compliance with results reporting at ClinicalTrials.gov. N Engl J Med 2015;372:1031-9. [Ref.ID 98939]
23. Cita con resumen
Hakala A, Kimmelman J, Carlisle B, Freeman G, Fergusson D. Accessibility of trial reports for drugs stalling in development: a systematic assessment of registered trials. BMJ 2015;350:h1116. [Ref.ID 98841]
24. Cita con resumen
Gulland A. WHO urges reporting of clinical trials within 18 months. BMJ 2014;349:g6292. [Ref.ID 98285]
25.Tiene citas relacionadas Cita con resumen
26.Tiene citas relacionadas Cita con resumen
Maund E, Tendal B, Hróbjartsson A, Jorgensen KJ, Lundh A, Schroll J, Gotzsche PC. Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications. BMJ 2014;348:g3510. [Ref.ID 98036]
27.Tiene citas relacionadas Cita con resumen
Doshi P, Zito J, dosReis S. Digging for data on harms in duloxetine trials. BMJ 2014;348:g3578. [Ref.ID 98035]
28. Cita con resumen
Kmietowicz Z. Transparency campaigners welcome new rules for clinical trials in Europe. BMJ 2014;348:g2647. [Ref.ID 97931]
29.Tiene citas relacionadas Cita con resumen
Torjesen I. Cochrane questions effectiveness of Tamiflu. BMJ 2014;348:g2675. [Ref.ID 97930]
30. Cita con resumen
32.
33. Cita con resumen
Smith R, Gøtzsche PC. Should journals stop publishing research funded by the drug industry? Yes. BMJ 2014;348:g171. [Ref.ID 97238]
34. Cita con resumen
Zorzela L, Golder S, Liu Y, Pilkington K, Hartling L, Joffe A, Loke Y, Vohra S. Quality of reporting in systematic reviews of adverse events: systematic review. BMJ 2014;348:f7668. [Ref.ID 97237]
35.
Goldacre B, Heneghan C. Improving, and auditing, access to clinical trial results. BMJ 2014;348:g213. [Ref.ID 97233]
36.Tiene citas relacionadas Cita con resumen
Kasenda B, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Tikkinen KAO, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Schandelmaier S, Xin S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M. Prevalence, characteristics, and publication of discontinued randomized trials . JAMA 2014;311:1045-52. [Ref.ID 97229]
38.
Barron H, Rosenblatt M. Access to patient-level trial data. N Engl J Med 2014;370:485-6. [Ref.ID 97072]
39.Tiene citas relacionadas
Ferri M, Abdallah K. Preparing for responsible sharing of clinical trial data. N Engl J Med 2014;370:484-5. [Ref.ID 97071]
40.Tiene citas relacionadas
Friedman AB. Preparing for responsible sharing of clinical trial data. N Engl J Med 2014;370:484. [Ref.ID 97070]
Seleccionar todas
 
<< anterior 21 a 40 de 512 siguiente >>